๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT ยท Real-Time Price ยท USD
27.17
-0.44 (-1.59%)
At close: Nov 19, 2026, 4:00 PM EST
27.20
+0.03 (0.11%)
Pre-market: Nov 20, 2026, 5:35 AM EST

Arcutis Biotherapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
508.68376.07196.5459.613.69-
Revenue Growth
60.00%91.34%229.73%1517.09%--
Gross Profit
463.81339.38177.4154.622.93-
Operating Income
35.16-12.23-128.4-241.1-301.63-206.53
Net Income
29.91-16.14-140.04-262.14-311.46-206.36
Earnings Per Share
0.22-0.13-1.16-3.78-5.66-4.18
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
ZORYVE Cream 0.3%
145.2212185.0829.193.69
ZORYVE Foam
254.8181.8971.54--
ZORYVE Cream 0.15%
97.7268.279.92--
ZORYVE Cream 0.05%
-0.91---
Other Segment
-43030.42-
Revenue (Total)
508.68376.07196.5459.613.69

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
259.46220.98227.96271.86409.59387.06
Total Debt
123.82114.52109.77205.92202.5477.56
Net Cash (Debt)
135.64106.46118.1965.95207.05309.5
Net Cash Growth
75.49%-9.92%79.22%-68.15%-33.10%10.74%
Net Cash Per Share
1.010.840.980.953.766.26

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
59.96-5.63-112.16-247.06-257.72-174.63
Capital Expenditures
-0.26-0.69-0.14-0.43-0.33-1
Free Cash Flow
59.71-6.31-112.3-247.49-258.05-175.62
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
91.18%90.24%90.27%91.63%79.54%-
Operating Margin
6.91%-3.25%-65.33%-404.49%-8183.04%-
Pretax Margin
6.06%-3.98%-70.92%-434.57%-8449.76%-
Profit Margin
5.88%-4.29%-71.25%-439.79%-8449.76%-
FCF Margin
11.74%-1.68%-57.14%-415.20%-7000.76%-

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
39.2676.62----
PS Ratio
6.759.468.305.11244.56-